Comera Life Sciences Holdings Balance Sheet Health
Financial Health criteria checks 4/6
Comera Life Sciences Holdings has a total shareholder equity of $102.3K and total debt of $389.9K, which brings its debt-to-equity ratio to 381.2%. Its total assets and total liabilities are $3.1M and $3.0M respectively.
Key information
381.2%
Debt to equity ratio
US$389.87k
Debt
| Interest coverage ratio | n/a |
| Cash | US$1.77m |
| Equity | US$102.26k |
| Total liabilities | US$2.97m |
| Total assets | US$3.07m |
Recent financial health updates
Recent updates
Comera Life Sciences rises on positive preclinical data from Sequrus study
Oct 18Comera life sciences expands woburn operations
Oct 04Comera Life Sciences announces up to $15M purchase agreement with Arena
Aug 31Comera Life Sciences GAAP EPS of -$1.14, revenue of $0.15M
Aug 10Comera Life Sciences Holdings (NASDAQ:CMRA) Is In A Good Position To Deliver On Growth Plans
May 27
Financial Position Analysis
Short Term Liabilities: CMRA's short term assets ($2.6M) do not cover its short term liabilities ($2.9M).
Long Term Liabilities: CMRA's short term assets ($2.6M) exceed its long term liabilities ($37.3K).
Debt to Equity History and Analysis
Debt Level: CMRA has more cash than its total debt.
Reducing Debt: Insufficient data to determine if CMRA's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CMRA has sufficient cash runway for 3 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: CMRA is forecast to have sufficient cash runway for 3 months based on free cash flow estimates, but has since raised additional capital.